Table 1 The demographic characteristics of the study participants:
Count | % | ||
|---|---|---|---|
Gender | Female | 200 | 50.0 |
Male | 200 | 50.0 | |
DM | No | 200 | 50.0 |
Yes | 200 | 50.0 | |
HTN | No | 352 | 88.0 |
Yes | 48 | 12.0 | |
Hypothyroidism | No | 215 | 53.8 |
Yes | 185 | 46.3 | |
Sub clinical hypo | No | 385 | 96.3 |
Yes | 15 | 3.8 | |
BMI | BMI < 20 | 127 | 31.8 |
BMI 20–25 | 147 | 36.8 | |
BMI 25–29 | 86 | 21.5 | |
BMI > 30 | 40 | 10.0 | |
Ultrasound | Normal | 0 | 0.0 |
Fatty liver | 400 | 100.0 | |
HBA1C | Normal | 200 | 50.0 |
On target | 112 | 28.0 | |
Elevated | 88 | 22.0 | |
T.G | Normal | 100 | 25.0 |
High | 300 | 75.0 | |
Cholesterol | Normal | 100 | 25.0 |
High | 300 | 75.0 | |
FIB-4 score | Low | 122 | 30.5 |
Intermediate | 191 | 47.8 | |
High risk | 87 | 21.8 | |
Fibroscan steatosis % | S0 | 0 | 0.0 |
S1 | 11 | 12.2 | |
S2 | 61 | 67.8 | |
S3 | 18 | 20.0 | |
Fibroscan fibrosis | F1 | 30 | 29.4 |
F2 | 47 | 46.1 | |
F3 | 24 | 23.5 | |
F4 | 1 | 1.0 | |
